BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KIVU-107 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of KIVU-107\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07229313-2578@assetmemo.bio
DTSTAMP:20261121T005737Z
DTSTART;VALUE=DATE:20280331
DTEND;VALUE=DATE:20280401
SUMMARY:KIVU-107: Phase 1 readout est. (NCT07229313)
DESCRIPTION:KIVU-107\, phase 1.\nStudy: A Study of KIVU-107 in Participants
  With Locally Advanced or Metastatic Solid Tumors\nEstimated primary compl
 etion: 31 March 2028. This is a ClinicalTrials.gov estimate\, not a confir
 med readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug
 /kivu-107#upcoming-events\nRegistry record: https://clinicaltrials.gov/stu
 dy/NCT07229313
URL:https://assetmemo.bio/drug/kivu-107#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
